Anodic Stripping Voltammetric Methods for Determination of Brexpiprazole and its Elec-Trochemical Oxidation Behavior in Pure Form and Pharmaceutical Preparations

Anodic Stripping Voltammetric Methods for Determination of Brexpiprazole and its Elec-Trochemical Oxidation Behavior in Pure Form and Pharmaceutical Preparations

Fathy M. Salama Khalid A.M. Attia Manal A. El-Shal Ragab A. M. Said Ahmed El-Olemy Ahmed M. Abdel-Raoof*

Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Al-Azhar University,11751, Nasr City, Cairo, Egypt

National Organization for Drug Control and Research (NODCAR), P. O. B 29 Cairo, Egypt

Corresponding Author Email: 
Ahmedmeetyazeed79@yahoo.com
Page: 
91-97
|
DOI: 
https://doi.org/10.14447/jnmes.v22i2.a05
Received: 
8 February 2018
|
Accepted: 
25 November 2018
|
Published: 
30 June 2019
| Citation

OPEN ACCESS

Abstract: 

The voltammetric behavior of brexpiprazole (BRX) was studied using cyclic voltammetry (CV), anodic stripping differential pulse (AS-DP) and anodic stripping square wave (AS-SWV) voltammetry at novel functionalized carbon paste electrode (FCPEs). Electrochemical oxidation behavior of brexpiprazole shows irreversible anodic peak at 0.87 V versus Ag/AgCl , in Britton– Robinson buffer (BR) at pH 4.0 , 50s preconcetration timeand-0.5 deposition potential. The peak current concentration relationship was rectilinear over the ranges of 6.64 x 10-7–3.2 x 10-6 and 6.64 x 10-8– 3.2 x 10-7 mol L-1with a minimum detection limit of 1.74 x 10-7 and 1.32 x 10-8 mol L-1 for AS-DP and AS-SWV respectively, The proposed meth-ods have been applied successfully for the analysis of the drug in pure and in its dosage forms.

Keywords: 

Anodic stripping, Differential Pulse Voltammetry, Square Wave Voltammetry, Brexpiprazole

1. Introduction

Brexpiprazole The drug received FDA approval for the treatment of schizophrenia and for adjunctive use for the treatment of major depres-sive disorder (mental disorder with low mode for at least two weeks) due to its dopamine D2 receptor partial agonist effect based on a clini-cal trial development programme that included two pivotal Phase III trials of brexpiprazole monotherapy in acute schizophrenia (1). This drug has high affinity for 5-HT1A, 5-HT2A, D2 and α1B, 2C receptors. It displays partial agonism at 5-HT1A and D2 receptors and potent antagonism at 5-HT2Aand α1B, 2C adrenergic receptors. It also has some affinity (antagonism) for D3, 5-HT2B, 5-HT7 and α1A, 1D receptors, and moderate affinity for H1 and low affinity for M1 receptors. It has antipsychotic effect to improve the sleep patterns and cognitive performance; also, it has the potential to treat anhedonia (a loss of capacity to feel pleasure) and cognitive deficits as core symptoms in major depressive disorder and schizophrenia with a few side effects. Usually augmented with other typical and some atypical antipsychotics drugs to improve both positive and negative symptoms (2).

Brexpiprazole is chemically designated as 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}-1,2-dihydroquinolin-2-one. Its molecular formula is C25H27N3O2S, and its molecular weight is 433.57. Brexpiprazole is a white-to-off white powder. It is practically insoluble in water and freely soluble in methanol [3]. A review of the literature revealed that a few analytical methods have been described for the determination of brexpiprazole in pharmaceutical by HPLC method [4], and in human urine sample with its metabolites using liq-uid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF).[5]

Up to date there is no study dealing with electrochemical behavior of BRX based on its oxidation or reduction, one aim of the present study was the investigation of electrochemical oxidation behavior of BRX using voltammetric methods. Development of new validated stripping voltammetric determination methods for the assay of BRX in pure form and pharmaceutical preparations. The proposed methods are more sensitive for determination of the drug in nanomolar concentra-tion in comparison to the reported HPLC methods. The electroanalyti-cal technique provides the advantages of simplicity, high sensitivity, low cost and relatively short analysis time, without any derivatization, extraction or clean-up steps [6, 7].

2. Experimental

Apparatus

• Metrohm electroanalyzers Model 797VA Computrace. The measure-ments were recorded using VA Computrace version 1.3.1.

• Jenway, 3510 pH meter (Jenway, USA).

• Hot plate (Torrey pines Scientific, USA).

• Centrifuge (TDL-60B) with max speed 6000 r/min. bench top (Hunan, China, Mainland).

• Functionalized carbon paste electrode as the working electrode, a Ag/AgCl (3 M KCl) electrode as the reference electrode,and a plati-num wire as the auxiliary electrode.

2.1. Materials and chemicals

2.1.1 Pure sample

Standard brexpiprazole powder was kindly supplied by Al-Andalus Pharmaceutical Company, Cairo, Egypt.

2.1.2 Pharmaceutical preparation

Rexulti ® tablets, each tablet claimed to contain 4 mg of brexpipra-zole, (B. No.- R01230382) manufactured by Otsuka Pharmaceutical Company, purchased from USA market.

2.1.3 Reagents and chemicals

• All chemicals used were of analytical grade, water used throughout the procedure was freshly bidistilled.

• Methanol and ethanol were analytical grade (Sigma–Aldrich, Ger-many).

• Orthophosphoric acid prepared as 0.04 M aqueous solution (Prolabo, Paris, France).

• Boric and acetic acids were prepared as 0.04 M aqueous solutions (Sigma-Aldrich, Germany).

• Sodium hydroxide prepared as 0.2 M and 1 M aqueous solutions (El- Nasr Company, Egypt). Britton Robinson (BR) buffer 0.04 M, was prepared by mixing the acid mixture containing 0.04 M phosphoric acid, 0.04M acetic acid and 0.04M boric acid [8]. Buffer solutions were adjusted with the appropriate amount of 0.2M sodium hydroxide to get the desired pH.

• Nitric acid (55.5 % w/w) , sulfuric (98% w/w) and ammonium sulfate powder were obtained from (El-Nasr Company, Egypt).

• High purity graphite powder (10-20 μm) and multi-wall carbon nanotubes (MWCNTs) powder (carbon >95.0%, O.D. x L 6-9 nm x 5 μm), were obtained from (Sigma-Aldrich, Germany).

Figure 1. Cyclic voltammogram of 1.31 x10-5 mol L-1 BRX in BR buffer of pH 4 at scan rate of 100 mV s-1 recorded at FCPEs.

2.2. Standard drug solutions

Stock drug solution (10-3 mol L-1) was prepared by dissolving 43.3 mg of BRX in 70 mL of methanol and the volume was completed to 100 mL with the same solvent. BRX working standard solutions were prepared daily by dilution of the stock solution with methanol

2.3. Procedures

2.3.1 Preparation of functionalized multi-walled carbon nanotubes

0.5 g MWCNTs were refluxed with H2SO4 + HNO3 (3:1) at 55 °C for 12 hours. The reaction mixture was stirred at 40 °C for 12 hours and diluted three times with 100 mL distilled water, filtered using centrifuge machine having 4,000 rpm. The process of centrifugation and washing off with distilled water repeated several times till neutral pH. Then the sample dried in vacuum oven at 60 °C for 24 hours to give carboxylated MWCNTs (MWCNTs-COOH). This leads to opening the caps of MWCNTs and formation of functionalized carbon nanotubes [9, 10].

2.3.2 Functionalized carbon paste electrode fabrication (FCPEs):

The carbon paste was prepared by mixing 0.49 g graphite powder and 10 mg MWCNTs-COOH with 0.3 mL of paraffin oil in an agate mortar with a pestle. A portion of composite carbon paste was packed into the hole of the insulin syringe body with diameter 3.0 mm which contacted with the apparatus through a copper wire. The fresh electrode surface was obtained by polishing the tip of the electrode against a weighing paper until it had a smooth and shiny surface appearance.

Figure 2. Reaction takes place during functionalization and sensing response

2.3.3 Electrochemical measurement

A 15 mL volume of BR buffer solution (pH= 4) containing a suitable amount of BRX was added to the sample cell to cover the final concentration ranges of 6.64 x 10-7 –3.2 x 10-6 and 6.64 x 10-8 – 3.2 x 10-7mol L-1 for AS-DP and AS-SWV respectively. The test solutions were purged with a stream of nitrogen for 5min. The working electrode was left at the optimum deposition potential for a given time period, and stirred at about 2000 rpm during the selected accumulation period. The stirring was then stopped and the solution allowed to rest for 5 s, after which a scan was carried out towards positive potentials over the range between 0.4 to 1.3 V, and the voltammograms were recorded. The experimental conditions for anodic stripping differential pulse voltammetry (AS-DP) were: pulse time, 0.04 s; voltage step, 0.006 V; pulse amplitude, 0.050 V; sweep rate, 0.040 V s−1; and voltage step time, 0.153 s. The experimental conditions for anodic stripping square wave voltammetry (AS-SWV) were: amplitude, 0.020 V; voltage step, 0.006 V; sweep rate, 0.03 V s−1 and frequency, 5.0 Hz.

2.3.4 Application to pharmaceutical formulation

Twenty Rexulti ® 4 mg tablets were accurately weighed and finely powdered, then a quantity equivalent to 43.3 mg of BRX was shaken with 50 mL of methanol for 10 minutes then filtered into 100 mL volumetric flask and the volume was adjusted to the mark with methanol to obtain a concentration of (1x10-3 mol L-1). Aliquots of the drug solution were introduced into the electrolytic cell and the general procedure was carried out.

3. Results and Discussion

3.1 Cyclic voltammogram

The cyclic voltammetric behavior of BRX at functionalized carbon paste electrode was studied (Fig. 1). BRX gave only an oxidation peak. On reverse scan, no reduction peak was observed; indicating that oxidation of BRX is an irreversible process at functionalized carbon paste electrode.

3.2 Effect of the functionalization of multi-wall carbon nanotubes

The performance characteristics of a given working electrode depend to a large extent on the nature and its composition; also, functionalization of CNTs overcomes slow and incomplete recovery of a bare CNTbased sensor and improves the interfacial interaction. The polar groups attached to the nanotubes surface increase the adsorption affinity of the electron-donor or acceptor due to their high surface-to-volume ratio and all these lead to enhancement of their sensing performance. Functionalized CNTs can be represented by Fig.2 and characterized by FTIR

Figure 3. FT-IR spectra of the (a) MWCNTs and (b) MWCNT-COOH powder samples.

3.3 Fourier Transform Infrared (FT-IR) Studies

FTIR spectra from the MWCNTs show a broad peak at 3459 cm−1 which is a characteristic of the OH stretch of hydroxyl group while carboxyl group on the surface of bare CNTs could be due to the partial oxidation of the surface of CNTs during purification by the manufacturer. Figure 3 shows the FT-IR spectra of the bare CNTs and functionalized CNTs. Figure. 2(b) shows other characteristic peaks of CNTCOOH at 1053cm-1 (C-O) 1640 cm-1 (C=C) and 1760 cm-1 (C=O).As compared with the FT-IR spectrum of CNTs (Fig. 3 (a)), appearance of new peaks at 1760 and 1053 cm-1 in Fig. 3(b) due to the stretching vibration of C=O and –C-O groups in the carboxyl group (-COOH), respectively.

Fig. 4 shows the cyclic voltammograms of 1.31 x10-5 mol L-1 of BRX in BR buffer pH 4 at scan rate of 100 mVs-1 at CPEs and FCPEs. At CPE electrode, the oxidation peak was observed at 0.87 V with current response 0.37 µA. Whereas at FCPEs, the current response increases to 0.48 µA (Fig.4) due to the enhancement of the electron transfer process and a larger intrinsic surface area of the functionalized electrode to amplify electrochemical signal and play a critical role in the enhancement of the electrochemical reaction.

Figure 4. Cyclic voltammograms of 1.31 x10-5 mol L-1 BRX in BR buffer of pH 4 at scan rate of 100 mV s-1 recorded at different working electrodes: CPEs and FCPEs.

Figure 5. The plot of the oxidation peak potential vs. pH of 1.31 x10-5 mol L-1 BRX at FCPEs

Figure 6. Effect accumulation potential on the oxidation peak potential of 1.31 x10-5 mol L-1 BRX at FCPEs.

3.4 Area of electrodes

The active surface area of the electrodes can be determined using the CV method using 20.0 mM K3Fe(CN)6 as a probe at different scan rates. For a reversible reaction, Randles-Sevcik equation can be applied: [11-14].

$\mathrm{I}_{\mathrm{P}}=\left(2.69 \times 10^{5}\right) \mathrm{n}^{3 / 2} \mathrm{ACD}^{1 / 2} \mathrm{v}^{1 / 2}$            (1)

Where, Ip refers to the anodic peak current, n is the number of electrons transferred, A is the active surface area of the electrode $\left(\mathrm{cm}^{2}\right), \mathrm{D}=$ diffusion coefficient $\left(\mathrm{cm}^{2} / \mathrm{s}\right) \mathrm{C}=$ is the concentration of $\mathrm{K}_{3} \mathrm{Fe}(\mathrm{CN})_{6}\left(\mathrm{mol} / \mathrm{cm}^{3}\right),$ and $\mathrm{v}=$ potential scan rate $(\mathrm{V} / \mathrm{s}) .$ for $20.0 \mathrm{mm} \mathrm{K}_{3} \mathrm{Fe}(\mathrm{CN})_{6}$ in $0.1 \mathrm{M} \mathrm{KCl}$ electrolyte, $\mathrm{n}=1, \mathrm{D}=7.6 \times 10^{-6} \mathrm{cm}^{2} \mathrm{s}^{-1},$ then the active sur-face area of the electrodes was calculated from the slope of the plot of Ip vs. $v^{1 / 2}$ and was found to be 0.044 and $0.148 \mathrm{cm}^{2}$ for bare CPEs and functionalized electrode respectively ,which explain the enhancement of anodic oxidation peak in case of FCPEs.

3.5 pH effect

The oxidation mechanism of BRX is depending on pH of the solution and this was obvious from negatively shifting in anodic peak potential with increasing of the solution pH which explains that protons participate in their electrode reaction processes figure.5. through the loss of two lone pair of electrons and one proton attached to nitrogen atom in the piperazine ring. The peak potential for BRX oxidation varies linearly with pH (over the pH range 2 - 6) which fit to the linear regression equations of E (V) = 0.986 - 0.028 pH, with determination coefficient (r2) = 0.9949The highest oxidation peak current was obtained at pH 4. At higher pH values after 6.0, peak potential values were pH independent. In medium having pH higher than 6.0, solubility of BRX decreases sharply and formation of precipitation occurs, hence at higher pH, electrochemical behavior of BRX was not studied. The slopes were found to be -0.028 mV per pH units and that was evidence that the number of transferred electrons and protons included in this mechanism is not equal. From the results obtained, the BR buffer of pH 4 was selected as the optimum pH used in further experiments (Fig. 5).

Figure 7. Effect accumulation time on the oxidation peak potential at of 1.31 x10-5 mol L-1 BRX FCPEs.

3.6 Effect of the accumulation potential

The effect of accumulation potential has been studied by the CV method (Fig. 6) shows the peak current vs. accumulation potential using 1.31 x10-5 mol L-1 of BRX at FCPs, at v = - 0.5 V s−1, and tacc=50s in BR buffer. In order to determine an ideal accumulation potential, the starting potential was varied in the range −0.6 to +0.2 V after an accumulation time of 50 s, upon negative shifting of the starting potential in the range+0.2 to−0.6 V, the peak current increases . This means that the mechanism of BRX accumulation is mainly due to electrostatic attraction on electrodes. The optimum accumulation potential value Eacc was determined to be − 0.5 V where The peak current reached to its maximum value and at this point it will be suitable for quantitative analysis.

3.7 Effect of the accumulation time

The effect of accumulation time has been studied by the CV method (Fig. 7) shows the peak current vs. accumulation time using 1.31 x 10-5 mol L-1 of BRX at FCPs, at v=0.1Vs−1, and Eacc = -0.5V in BR buffer. The influence of accumulation time ranging between 25 and 180 s has been studied. The optimum accumulation time value tacc was determined to be 50 s where The peak current reached to its maximum value and at this point it will be suitable for quantitative analysis.

3.8 Effect of scan rate

The influence of scan rate ν (ranging from 20 to 200 mV s-1 ) on the oxidation peak currents of BRX (1.31 x 10-5 mol L-1) was examined at FCPEs in BR buffer (pH 4) and a linear relationship is found for the logarithm of the oxidation peak currents and the logarithm of the scan rates (Fig. 8). The oxidation peak current increases linearly with the linear regression equation as

Figure 8. The plot of logarithm of peak current vs. the logarithm of the scan rate of BRX at FCPEs

Figure 9. Dependence of peak potential on the logarithm of the scan rate of BRX at FCPEs.

$\log \operatorname{Ip}(\mu \mathrm{A})=0.698 \log v\left(\mathrm{Vs}^{-1}\right)+1.455 \mathrm{r}^{2}=0.990$       (2)

The value (0.698) in between 0.5-1.0 of the slope is observed, suggesting a mixed diffusion–adsorption controlled occurring at FCPEs [15].

In case of irreversible electrode process, the peak potential (Ep) and scan rate (ν) are defined by the following Laviron equation.[16]

$\mathrm{Ep}=\mathrm{E}^{\circ}+2.303 \mathrm{RT} / \mathrm{anF}\left[\log \mathrm{RTK}^{\circ} / \mathrm{anF}+\log \mathrm{v}\right]$                 (3)

where α is the electron transfer coefficient, n is the number of electrons, T is the temperature (298 K), R is the gas constant (8.314 J K mol-1 ) and F the Faraday constant (96 485 C mol-1 ), respectively. Thus we can calculate αn from the slope of the relation between Ep versus log ν. In this case, the slope value is 0.064; αn value was calculated to be 0.906. Generally, α (electron transfer coefficient) was assumed to be 0.5. Thus, the value of electrons number n =1.81 (≈ 2) was obtained confirming the proposed electro-oxidation mechanisms of BRX as shown in (Fig. 9). Same parameter (αn) was calculated from Eq.(4) in which the difference between peak potential and half-peak potential is expressed [17] for cyclic voltammograms and it was calculated to be 48 mV .

Figure 10. Proposed oxidation mechanism of BRX at FCPEs.

$/ \mathrm{E}_{\mathrm{p}}-\mathrm{E}_{\mathrm{p}, \mathrm{h}} /=\frac{(1.857 \mathrm{RT})}{\beta n F}$ and $\mathrm{at} 25^{\circ} \mathrm{C} / \mathrm{E}_{\mathrm{p}}-\mathrm{E}_{\mathrm{p}, \mathrm{h}} /=\frac{(47.7)}{\beta n}$

In this equation, Ep,h is half peak potential in mV and other abbreviations have the same meaning as in Eq.(3). αn value was calculated to be 0.993. Thus, the value of electrons number n =1.98 (≈ 2) When these results and the limiting values for the charge transfer coefficient (between 0 and 1.0) [17–19] were evaluated, the number of electrons in electrode process could be predicted as 2.

3.9 Proposed oxidation mechanism of BRX

Depending on former results, two electrons and one proton participate in the electrode process of BRX at FCPEs (Fig. 10) which is compatible with previously results for oxidation of piperazine ring [20-22].

3.10 Method Validation

The analytical method was validated according to the international conference on Harmonization (ICH) [23].

3.11 Linearity and range

Linearity relationship was verified over the concentration ranges indicated in Table 1 for both AS-DPV and AS-SWV techniques as shown in (Figs. 11 and 12). Statistical analysis of the data gave high values of square correlation coefficient (R2) and small values of standard deviation (SD) and relative standard deviation (RSD) which figures out the low scattering of the points around the calibration graph and proved linearity of the method over the specified concentration range [24,25] (Table 1).

3.12 Limit of detection (LOD) and limit of quantitation (LOQ)

LOD and LOQ were calculated according to the following equations as specified by ICH guidelines.

$\mathrm{LOD}=3.3 \mathrm{\sigma} / \mathrm{S}$

$\mathrm{LOQ}=10 \sigma / \mathrm{S}$

where σ is the standard deviation of y-intercepts of regression lines and S is the slope of the calibration curve. The results are summarized in Table 1, indicated that the proposed methods is more sensitive than other reported methods to detect the lowest amount of BRX concentration.

3.13 Accuracy

The accuracy of the proposed voltammetric methods for the determination of BRX was studied. The results obtained were summarized in Tables (1) which confirmed that the proposed methods are accurate, as indicated by the percentage recovery values. Accuracy Table 2 which indicates no matrix interference.

Figure 11. Differential pulse anodic strippig voltammograms of solutions with different BRX concentrations in BR buffer of pH4.0, preconcentration time and preconcentration potentials are 50s and -0.5V, respectively.

3.14 Precision

The intra- and inter-day precision was calculated by assaying freshly prepared solutions of analyte in triplicate on the same day (the repeatability) and on three different days (intermediate precision), respectively using the proposed voltammetric methods. The repeatability (intra-day) and intermediate precision (inter-day) of the results obtained by the proposed AS-DP and AS-SWV procedures were examined and the results indicated high precision of the proposed procedure and proved to be suitable for quality control of BRX (Table 1).

Figure 12. Square-wave anodic strippig voltammograms of solutions with different BRX concentrations in BR buffer of pH4.0, preconcentration time and preconcentration potentials are 50s and -0.5V, respectively.

3.15 Robustness

The robustness of the proposed voltammetric method can be determined by studying an ability of the method to kept unaffected by even a small deliberate variation in method parameters conditions such as pH (±0.1) and the resting time before each measurement (5s $\pm$ 1s). It is applied by changing only parameter while the other conditions remain constant; no observable changes were noted in the results, confirming robustness of the procedure [26, 27]. These minor changes that may take place during the experimental operation did not affect the peak current intensity of the studied drug, indicating the reliability of the proposed method during normal usage (Table 1).

Table 1. Regression and validation data for the determination of BRX by the proposed voltammetric procedures at FCPEs.

parameter

 

AS-DP

AS-SW

Working electrode potential (mV)

 

0.846

0.84

Range (mol L-1)

 

6.64 x 10-7–3.2 x 10-6

6.64 x 10-8–3.2 x 10-7

Slope ($\mu \mathrm{A}$)

 

0.1018

0.1711

Intercept ($\mu \mathrm{A}$)

 

0.1346

0.0194

Square Correlation coefficient (R2)

 

0.9994

0.9996

LOD (mol L-1)

 

1.74 x 10-7

1.31x 10-8

LOQ (mol L-1)

 

5.3 x 10-7

3.99 x 10-8

Accuracy (%R)

 

98.77

100.98

Precision(%RSD)

Repeatabilitya

Intermediate precisionb

1.213

0.987

0.879

0.642

Robustnessc ( Mean±%RSD)

 

98.45±1.05

101.45±1.45

aAverage of three different concentrations for brexpiprazole repeated three times within the day. bAverage of three different concentrations for brexpiprazole repeated three times in three days. cVariation in method parameters such as pH of the sample.

Table 2. Recovery study of BRX by standard addition technique using the proposed voltammetric procedures at FCPEs.

Standard added x10-6

Tablet taken x10-6

Found x10-6

Recovery %

Standard added x10-7

Tablet taken x 10-7

Found x10-7

Recovery %

AS-DP

AS-SWV

0.99

0.5

0.98

98.99

0.99

0.5

0.97

97.97

1.33

1.34

100.75

1.33

1.32

99.25

1.65

1.66

100.60

1.65

1.64

99.39

1.99

1.98

99.49

1.99

2.01

101.00

2.37

2.35

99.15

2.37

2.38

100.42

mean

99.80

0.826

99.60

1.172

%RSD

3.16 Application

The proposed method was applied to the quantitative analysis of BRX in pharmaceuticals preparations. There are no any oxidative compounds or extra noises peaks found in different matrices are seen in the potential range of an interested the analytical peak. The results obtained assure the validity of the proposed voltammetric methods for the determination of BRX in tablets. These results reveal that both AS-DP and AS-SWV methods had adequate precision and accuracy and consequently can be applied to the determination of BRX in pure and pharmaceutical preparations without any interference. The results obtained by the proposed voltammetric and the reported methods [4] were statistically compared, confirming that a good accuracy and precision of the proposed method for the analysis of the BRX in its pharmaceutical dosage form, as shown in Table 3. By applying of t-test and F-test at 95 % confidence level, there are no significant differences [28].

Table 3. Statistical comparison of the results obtained by the proposed voltammetric and the reported methods.

parameter

AS-DP

AS-SWV

Reported method(4)

N*

5

5

5

X‾**

99.61

99.56

99.26

SD

0.806

0.873

1.031

Variance

0.649

0.609

1.039

Student's t-test

0.574

(2.306)***

0.478

(2.306)***

F-value

1.600

(6.338)***

1.706

(6.338)***

* Number of experiments; ** the mean of percent recovery of brexpiprazole. *** The values in parenthesis are tabulated values of “t “and “F” at (P = 0.05). (4) HPLC method using a mobile phase consists of 0.1%v/v Formic acid in water: Methanol (35:65).

4. Conclusion

In the present work, novel sensor based on modification of CPEs with functionalized carbon nanotubes was used for electrochemical determination of BRX. The advantage of the functionalization of carbon nanotubes was enhancing the sensitivity of the CPEs towards BRX. The results showed that the method is a simple, sensitive, easyto-handle, and rapid for the determination of BRX in pure and pharmaceutical preparations with good precision, accuracy, selectivity and very low detection limit. A high percentage of recovery and low % RSD values of proposed anodic stripping methods indicate that these methods are suitable for the routine determination of the drug in quality control laboratories without interference from other ingredients

Acknowledgment

The authors thank Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University for supporting this work.

  References

[1] L. Citrome, Int J Clin Pract., 69, 978 (2015).

[2] S. Das, P. Barnwal, W.A. Blessed, S Mondal, I. Saha,Ther. Adv. Psychopharmacol., 6, 39 (2016).

[3] Wikipedia [internet], [reviewed 2017 Sep 2; cited 2017 Sep 27]. Available from:https://en.wikipedia.org/wiki/ Brexpiprazole, oct. 4th, 2017.

[4] A. Sravani , C.H.N. Durga, U. Divya, C.H. Suneetha, P. Suresh, B. T. Rao, C. Sudheer,. Indo. Am. J. Pharm. Res., 7, 8560 (2017).

[5] J. R. Enders, S.G. Reddy, E. C. Strickland, G. L. McIntire, Clin. Mass. Spectrom., 6, 21 (2017).

[6] F. Sayin, S. Kir, J. Pharm. Biomed. Anal., 25, 153 (2001).

[7] S.A. Ozkan, B. Uslu, P. Zuman, Anal. Chim. Acta., 457, 265 (2002).

[8] J. Heyrovsky, P. Zuman, in: Practical Polarography, Academic Press, New York, 163, 1968.

[9] P. M. Kadam, N. L.Tarwal, S. S. Mali, H. P. Deshmukh and P. S. Patil, Electrochimica Acta, 58, 556 (2011).

[10] S. H. Pisal, N. S. Harale, T. S. Bhat, H. P. Deshmukh,and P. S. Patil, (IOSR-JAC), 7, 49 (2014).

[11] Attia A.K, Badawy A.M., Abd-Elhamid S.G., RSC Adv., 6, 39605 (2016).

[12] B. Rezaei, S. Damiri, Sens. Actuators. B -Chem., 13, 324 (2008).

[13] B. Rezaei, Z.M. Zare, Anal. Lett., 41, 2267 (2008).

[14] K.M. Naik, S.T. Nandibewoor, Sens. Actuators. A- Phys., 212, 127 (2014).

[15] B. Dogan-Topal, B. Bozal-Palabıyık, B. Uslu, S.A. Ozkan, Sens. Actuators. B- Chem., 177, 841 (2013).

[16] E. Laviron, J. Electroanal. Chem. Interfacial Electrochem., 101, 19 (1979).

[17] C.M.A. Brett, A.M.O. Brett, Electrochemistry, Principles, Methods and Applications, 1st ed., Oxford University Press, New York, 1993.

[18] J. Wang, Analytical Electrochemistry, 2nd ed., A John Wiley & Sons, Inc. Publication, New York, 2000.

[19] H. Lund, O. Hammerich (Eds.), Organic Electrochemistry, 4th ed., Marcel Dekker Inc., New York, 2001.

[20] A. Shalaby,W. S. Hassan, H.A.M. Hendawy, A.M. Ibrahim. J. Electroanal. Chem., 763, 51 (2016).

[21] J.M. Kauffmann, J.C. Vire, G.J. Patriarche, L.J. Nunez-Vergara, J.A. Squella, Electrochim. Acta, 32, 1159 (1987).

[22] R.N. Hegde, N.P. Shetti, S.T. Nandibewoor, Talanta, 79, 361 (2009).

[23] International Conference on Harmonization, ICH Harmonised Tripartite Guideline. Validation of analytical procedure: text and methodology, Q2 (R1). International Conference on Harmonization, Geneva, 2005.

[24] M. Rizk, E. A. Taha, S. Mowaka, Y. M. Abdallah, J. Chromatogra. Sci., 53, 742 (2015).

[25] M.F. Ayad, N. Magdy, Chemical and Pharmaceutical Bulletin., 63, 443 (2015).

[26] The united States Pharmacopoeia, National Formulary, “25th ed. United States Pharmacopoeia Convention: Rockville, MD” [USA] (2007).

[27] M. El-Tohamy, S. Razeq, M. El-Maamly, A. Shalaby, Cen. Eur. J. Chem., 8, 937 (2010).

[28] Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford (UK): Blackwell; 1994.